Publications

Found 299 results
Filters: Author is Elemento, Olivier  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
Finnerty BM, Moore MD, Verma A, Aronova A, Huang S, Edwards DP, Chen Z, Seandel M, Scognamiglio T, Du Y-CNancy et al..  2019.  UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.. Endocr Relat Cancer. 26(4):411-423.
Chu C-S, Hellmuth JC, Singh R, Ying H-Y, Skrabanek L, Teater MR, Doane AS, Elemento O, Melnick AM, Roeder RG.  2020.  Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage.. Mol Cell. 80(5):845-861.e10.
Elemento O, Slonim N, Tavazoie S.  2007.  A universal framework for regulatory element discovery across all genomes and data types.. Mol Cell. 28(2):337-50.
De Renzis S, Elemento O, Tavazoie S, Wieschaus EF.  2007.  Unmasking activation of the zygotic genome using chromosomal deletions in the Drosophila embryo.. PLoS Biol. 5(5):e117.
Robinson BD, Vlachostergios PJ, Bhinder B, Liu W, Li K, Moss TJ, Bareja R, Park K, Tavassoli P, Cyrta J et al..  2019.  Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling.. Nat Commun. 10(1):2977.
Dooley BJ, Verma A, Ding R, Yang H, Muthukumar T, Lubetzky M, Shankaranarayanan D, Elemento O, Suthanthiran M.  2020.  Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts.. Transplant Direct. 6(8):e588.
Verma A, Muthukumar T, Yang H, Lubetzky M, Cassidy MF, Lee JR, Dadhania DM, Snopkowski C, Shankaranarayanan D, Salvatore SP et al..  2020.  Urinary cell transcriptomics and acute rejection in human kidney allografts.. JCI Insight. 5(4)
Giannopoulou EG, Elemento O, Ivashkiv LB.  2015.  Use of RNA sequencing to evaluate rheumatic disease patients.. Arthritis Res Ther. 17:167.
Wacker SA, Houghtaling BR, Elemento O, Kapoor TM.  2012.  Using transcriptome sequencing to identify mechanisms of drug action and resistance.. Nat Chem Biol. 8(3):235-7.